Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate-to-severe atopic dermatitis treated with dupilumab.

MLA

Martinez-Cabriales, Sylvia, et al. “Multicenter Canadian Case Series of Pediatric Patients Less than 12 Years of Age with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab.” Pediatric Dermatology, vol. 41, no. 1, Jan. 2024, pp. 5–11. EBSCOhost, https://doi.org/10.1111/pde.15418.

APA

Martinez-Cabriales, S., Marcoux, D., Liy-Wong, C., Prajapati, V. H., Sibbald, C., Cunningham, N., Lansang, P., Tonkin, R., Joseph, M., Wong, L., Spring, S., Gavigan, G., & Ramien, M. (2024). Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate-to-severe atopic dermatitis treated with dupilumab. Pediatric Dermatology, 41(1), 5–11. https://doi.org/10.1111/pde.15418

Chicago

Martinez-Cabriales, Sylvia, Danielle Marcoux, Carmen Liy-Wong, Vimal H Prajapati, Cathryn Sibbald, Natalie Cunningham, Perla Lansang, et al. 2024. “Multicenter Canadian Case Series of Pediatric Patients Less than 12 Years of Age with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab.” Pediatric Dermatology 41 (1): 5–11. doi:10.1111/pde.15418.